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Abstract
Background: The aim of this work was to study the implementation mechanisms established earlier, the anti-inflammatory activity of a new compound 
– di-(2,4-dimethyl) malonic acid anilide, code name – “Maldian”.
Material and methods: The study was performed on nonlinear white male rats, weighing 220-250 g. The implementation mechanisms of maldian 
pharmacological action studied in terms of the effect of a new substance on the level of prostaglandin E and the effect on the activity of proteolytic enzymes 
of the kinin system in the blood of intact animals on the background of carragenine edema. Maldian antioxidant activity was assessed by the impact 
on the processes of lipid peroxidation in the membranes of liver mitochondria in rats. The role of adrenal system showing maldian anti-inflammatory 
effect was also studied.
Results: It is found that maldian at a dose of 7.3 mg/kg has a pronounced antioxidant activity reducing free radicals oxidation processes. There is an 
ability to inhibit kininogens, to inhibit the activity of the leading mediator of inflammation – kallikrein in the mechanism of anti-inflammatory maldian 
activity.  Maldian significantly decreases the level of prostaglandin E on the background of acute inflammatory reaction. Anti-inflammatory maldian 
activity is implemented without any effects on the adrenal cortex.
Conclusions: Considering the results obtained, maldian – (di-(2,4-dimethyl) anilide malonic acid, is a promising compound for further pharmacological 
study and introduction into medical practice as a new modern drug with anti-inflammatory action.
Key words: derivatives of malonic acid, anti-inflammatory action mechanisms.
Introduction
Inflammation, as a typical pathological process, is the 
leading link of the pathogenesis of many diseases of a mod-
ern man. An inflammatory reaction is characterized by a 
symptom complex of functional, structural and metabolic 
abnormalities at the organ and cellular levels [1]. The main 
humoral factors of an inflammatory reaction on the stage 
of secondary alteration are: the activation of free radicals 
oxidation (FRO) due to the increased release of aggressive 
oxygen and oxygen-halogen radicals, and a significant de-
cline in the capacity of endogenous antioxidant systems; 
the amplification by activated macrophages and endotheli-
al cells synthesis of nitric oxide, which has potent non-spe-
cific cytotoxic effect; the release into the blood components 
of the complement system, in particular the membrano-
atacking complex C5-C9, which violates the integrity of 
the cell membrane; the activation of hydrolytic enzymes 
of the lysosomes releasing when cells die; the increase of 
the synthesis and the release by activated macrophages and 
T-lymphocytes of tumor necrosis factor (TNF), the last can 
cause apoptosis and cell death, increases the generation of 
inflammation focus of the nitric oxide and activates the 
processes of the FRO.
The cellular factors of secondary alteration are neutro-
phils and macrophages [2]. It should also be noted that the 
most important mediator element of the inflammatory re-
sponse are eicosanoids, which are the main producers in 
the inflammation of the monocytes and macrophages [3].
The predominant eicosanoids in the inflammation fo-
cus are considered as prostaglandin – PGЕ1 and PGЕ2, 
leukotriene – LТВ4 and 5-hydro-peroxyisobutyrate acid. 
Thromboxane A2, prostacyclin I2 and leukotrienes LTS4, 
LТD4, LTE4 are produced in a smaller number [4].
A particularly important role in the development 
mechanism of inflammatory reactions is about prostaglan-
dins, which, showing a powerful vasodilatation effect, in-
crease hyperemia and exudation. PGЕ1 and PGЕ2 increase 
the sensitivity of afferent receptors to bradikinin and hista-
mine; also they induce temperature increase [5].
Considering the above the activation of the FRO and 
the synthesis changes and the activity of prostaglandins 
play the key role in the modulation of the inflammatory re-
sponse, so there is an urgent search and the development of 
a new drug with anti-inflammatory action, in implementa-
tion of which the leading targets are: the inhibition of FRO 
processes and the effect on the level of inflammatory me-
diators – kinins and prostaglandins E [6, 7, 8].
In this aspect a promising remedy can be a new com-
pound di-(2,4-dimethyl) anilide malonic acid, synthesized 
by the scientists of the National University of Pharmacy 
(Kharkiv, Ukraune).
The aim of this work was to study the realization mech-
anisms of previously shown anti-inflammatory effect of 
di-(2,4-dimethyl) anilide malonic acid, from now on “Mal-
dian” [9].
Material and methods
The study was performed on nonlinear white rats. The 
animals were kept in standard conditions of a vivarium in 
accordance with Good Laboratory Practics. The experi-
ments were carried out in order to meet the requirements 
of European Community Council Directive on the protec-
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tion of animals used for experimental and other scientific 
purposes [10]. The studies were carried out on 128 non-
linear male rats weighing 220-250 g. The animals were di-
vided into groups of 8.
The anti-inflammatory maldian activity was studied on 
the model of carrageenan foot swelling in rats, which was 
modeled by subplanetary injection of 0.1 ml of 1% solution 
carrageenan. In accordance with methodical recommen-
dations on the study of anti-inflammatory activity of new 
drugs maldian was injected intragastrically 30 min before 
modeling pathology at a dose of 7.3 mg/kg [11]. The ace-
tylsalicylic acid at a dose of 98 mg/kg and voltaren at a dose 
of 8 mg/kg were used as reference drugs and were injected 
in accordance with the scheme which was similar.
The study of mechanisms of maldian anti-inflammato-
ry activity was conducted through 3 stages (tab. 1).
Table 1
The studying stages of realization mechanisms of 
maldian anti-inflammatory activity
Stages Studying model / Conditions
The index under 
study
Stage 1 Acute carrageenan of foot swell-
ing in rats




Stage 2 Microsomal fraction of homog-
enate in rats liver
The concentration of
malonic dialdehyde
Stage 3 Acute carrageenan of foot 




During the first stage under the conditions of repro-
duced carrageenan inflammation, 4 hours after carrageen-
an injection, blood sampling was conducted and examined 
whether PGЕ1 is contained as well as the level of kallikrein 
and kallikreinogen. The rats were decapitated under ether 
anesthesia to sample blood.
The level of prostaglandin E1 (PGЕ1) was determined 
in radioimmunology way using «Clinical Assay» (USA) 
reagents. The determination of PGЕ1 content in blood 
plasma was carried out on the background of the inflam-
matory response. Blood for the determination of PGЕ1 
was sampled in plastic tubes in accordance with V. D. Po-
mognemo and co-authors’ recommendations [12].  To pre-
vent the processes of biosynthesis and metabolism PGЕ1, 
the transition from one series to another, the test tubes 
while sampling and processing blood were placed in ice. 
As an anticoagulant ethylenediaminetetraacetate (EDTA) 
at a concentration of 1 mg/ml of blood was used. To block 
the cascade of eicosanoids transformations by platelets in 
the tubes, the inhibitor prostaglandinsynthase –a solution 
of acetylsalicylic acid (0.01 ml of 0.4% solution of 1 ml of 
blood) was added to the plasma samples.
The plasma was separated by centrifugation at a tem-
perature of 4 ° C. and 2000 rpm for 30 min. until complete 
precipitation of platelets and stored at -20 degrees C for 2-3 
days. PGЕ1 extraction from plasma was performed using 
ethyl acetate and a preliminary removal of plasma neutral 
lipids using petroleum ether.
Kallikrein and kallikreinogen in the serum were deter-
mined spectrophotometrically by the rate of hydrolysis of 
the ethyl ester of N-benzoyl – L-arginine by the method of 
and T. S. Paskhina and A. V. Krinskaya [13].
During the second phase of the experiment the pres-
ence of antioxidant activity in the mechanism of maldian 
anti-inflammatory action was being studied.
The impact of a new compound on the intensity of lipid 
peroxidation (LPO) was studied in vitro using microsomal 
fraction of homogenate of rat’s liver. The intensity of Fe2+ 
– ascorbate -induced by LPO of microsome membranes 
was determined according to the standard procedures. 
The intensity of NADPH-dependent of LPO of microsome 
membranes was determined in the medium of the follow-
ing composition: 100 mmole of Tris-HCL buffer (pH 7.4), 
1 mmole of NADPH, 4 mmole of ADP, 14 µmol of Mohr’s 
salt. In ascorbinsaeure LPO the medium contained 100 
mmole of Tris-HCL buffer (pH 7.4), 0.5 mmol of ascorbate, 
12 μmol Mohr's salt. During some experiments, 4 mmole 
ADP (Sigma, USA) was additionally injected into the incu-
bating medium. The concentration of microsome protein 
in the incubating mixture was 0.5-0.6 mg in 1 ml. Warmed 
up to 37 degrees air was constantly purged through the in-
cubating mixture, providing the saturation of the medium 
with oxygen and mixing. The concentration of malonic di-
aldehyde (MDA) was determined spectrophotometrically 
by the reaction of thiobarbituric acid, using SF-16, after 
protein precipitation by trichloroacetic acid. Maldian was 
injected into the incubating medium at doses of 7.3 µm 
and 14.6 µm. As a reference drug voltaren at concentra-
tions of 80 µm, 500 µm and 800 µm was selected [11].
The third phase of the research was devoted to the 
study of a possible involvement of the adrenal system in 
the mechanism of realization of maldian anti-inflamma-
tory effect.
To ascertain the mechanism of maldian anti-inflamma-
tory action of the adrenal system, the series of experiments 
with carrageenan swelling in rats with previously cut out 
adrenal glands were carried out. The adrenalectomy was 
performed bilaterally on the back under ethaminal-sodi-
um anesthesia. 5 days after the surgery, the rats were simu-
lated carrageenan swelling of the foot in accordance with 
the standard method described in methodical recommen-
dations on the study of anti-inflammatory activity of new 
drugs [11].
The statistical processing of experiment results was 
done by common pharmacology methods determining the 
average arithmetic meanings (X) and a standard error (SE), 
the reliability of differences was determined using t-Stu-
dent test at the significance level of 95% (p £ of 0.05) [14].
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Results and discussion
Acute carrageenan swelling is characterized by a signif-
icant inflammatory reaction (table 2). It is found out that a 
new compound anti-inflammatory activity is at the level of 
a known drug with anti-inflammatory effect of voltaren. It 
gives us the grounds to study the implementation mecha-
nisms of maldian anti-inflammatory activity in details.
Table 2
Antiexudative activity of maldian and voltaren under the 
condition of acute carrageenan swelling (n=8)
The condi-






1 hour 2 hours 3 hours 4 hours 
Maldian 7,3 26,3±0,84 35,7±1,72 48,8±2,12 56,9±0,97
Voltaren 8,0 24,0±2,10 33,0±2,70 46,2±2,20 55,0±2,30
Today, the leading role of prostaglandins E – lipid me-
diators of inflammation which has potent phlogogenic and 
pyrogenic effect of PGЕ1 is a scientific fact. [15]. The first 
phase of the experiment was devoted to the study of mal-
dian influence on PGЕ1 content in the blood plasma in the 
acute inflammatory response (within 4 hours after Karenin 
injection). The results of the experiment are presented in 
table 3.
Table 3
The influence of maldian and reference drugs on 
the content PGЕ1 in the blood plasma of rats with 
carrageenan swelling  
(4 hours after carragenan injection) (n=8 )
The conditions
of the experiment
The content PGЕ1 in plasma 
Nmol/l
% to intact 
control
Intact control 8,0±1,58 100
Control pathology 13,8±1,18 * 172
Maldian, of 7.3 mg/kg 0,68±0,39 * # 8,5
Acetylsalicylic acid, 98 mg/kg 0,24±0,08 * # 3,0
Voltaren, 8 mg/kg 1,17±0,38 * # 15
Notes: * – statistically significant differences relatively to the intact 
control group – p<0.05; # – statistically significant differences 
relatively to the control pathology group – p<0.001.
It is found out that rats of the control pathology group 
have acute inflammatory reaction (4 hours after Karenin 
injection) which is accompanied by a significant increase 
up to 72% level of PGЕ1 in plasma, relatively of intact 
animals.
Maldian injection is characterized by a pronounced 
anti-inflammatory effect, verified by a large-scale reduc-
tion in prostaglandin fractions on the background of acute 
inflammatory reaction. Maldian reduces the amount of 
studied prostaglandin by 20 times (p<0.001) relatively to 
the control group pathology.
It should be noted that the effect of a new compound on 
the level of prostaglandin E in terms of the inflammatory 
response, is at the level of reference drugs – acetylsalicylic 
acid and voltaren and slightly higher than the activity of 
the latter.
Taking into account the findings of previous studies 
[9] it is possible to note a high degree of the correlation 
between the anti-inflammatory effect of a new compound 
and its effect on the level of PGE1 in plasma.
Kinins are important modulators of the inflamma-
tion.  Regardly to that, maldian effects on the activity of 
proteolytic enzymes of the kinin system in terms of carra-
geenan inflammation were studied. The results are shown 
in table 4.
Table 4
Maldian and acetylsalicylic acid influence on the 
content of kallikrein and kallikreinogen in the blood 
plasma of rats in the norm and on the background of 
carrageenan swelling  







Intact control 84,6±2,2 240,5±5,5
Control pathology (carrageenan 
swelling)
128,4±3,8 * 327,6±14,3 *
Maldian, of 7.3 mg/kg 39,5±5,1 * # $ 248,8±12,4 * # $
Carrageenan swelling + Maldian, 
of 7.3 mg/kg
44,5±3,9 * # $ 336,6±15,4 * $
Acetylsalicylic acid, 98 mg/kg 66,3±4,3 * # 421,4±13,1 * #
Carrageenan swelling + Acetyl-
salicylic acid, 98 mg/kg
70,3±4,8 * # 422,3±11,4 * #
Notes: * – statistically significant differences relatively to the intact 
control group – p<0.01; # – statistically significant differences 
relatively to the control pathology group, p<0.01; $ – statistically 
significant differences relatively to the group of acetylsalicylic acid 
– p<0.01.
It was found out that in animals under the conditions 
of acute inflammatory response, induced by carrageenan, 
there has been a significant increase in the level of kalli-
krein up to 52% and kallikreinogen by 36%, relatively to 
the group of intact control.
While injecting maldian it was found out a significant 
reduction of kallikrein up to 47% relatively to the control 
pathology group (table 4), meanwhile maldian has no sta-
tistically significant effect on plasma levels of kallikreino-
gen.
Acetylsalicylic acid contributed to the increase of kal-
likreinogen content in the blood plasma of healthy animals 
up to 75% relatively to the intact control group; meanwhile 
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it significantly less pronouncedly reduced the concentra-
tions of kallikrein relatively to maldian.
The results obtained show that the studied compound 
inhibits the release of one of the leading mediators of kal-
likrein inflammation.
Due to the fact that the inflammatory reaction triggers 
the cascade of FRO, the next step was the studying of the 
potential antioxidant maldian action on the model of in-
duced LPO in the membranes of mitochondria of rat liver. 
Divalent iron ions and ascorbate were used as inductors 
(prooxidant). The results of the experiment are shown in 
table 5.
Table 5
The dynamics of changes in the concentration of 
malondialdehyde (MDA) in liver cells of rats under the 
conditions of Fe2+ – ascorbate dependent LPO and when 
added maldian and voltaren to the incubation medium 
The conditions of
the experiment/ the  
concentration of the introduced 
substances, µm
The accumulation of MDA 
whithin 5 min of incubation
nmol/l % control
The study of the maldian effect
Control (induction LPO) 24,4±0,40 100
Maldian, 3.6 μm 26,4±0,60 108
Maldian, of 7.3 μm 15,2±0,70 * # 62
Maldian, of 16.6 μm 11,5±0,73 * # 47
The study of voltaren effects
Control (induction LPO) 27,5±0,40 100
Voltaren, 80 µm 33,0±0,68 120
Voltaren, 500 µm 16,5±0,50 * $ 60
Voltaren, 800 µm 13,6±0,32 * $ 9
Notes: * – statistically significant differences relatively to the control 
group (induction of LPO) – p<0,001; # – statistically significant 
differences relatively to maldian group at a dose of 3.6 μm – p<0.001; 
$ – statistically significant differences relatively to voltaren group at 
a dose of 80 μm – p<0.001.
In the groups, which caused the intensification of LPO 
processes due to the injection of prooxidant, the concen-
tration of MDA (as a marker of LPO processes) was taken 
as 100 %.
Dose-dependent antioxidant maldian effect was found 
out. So, if you increase the dose of  maldian from 3.6 µm to 
7.3 µm, its ability to inhibit Fe2+ – ascorbinsaeure LPO in 
the mitochondria of rat liver is increased by 1.7 times and 
the subsequent doubling of the dose reduces pathological 
oxidation processes by 2,3 times (table 5).
Inhibitory effect of voltaren on the oxidation of mem-
brane lipids of mitochondria was observed at concentra-
tions of 500 µm and 800 µm, which accounted for 60% and 
49%, respectively.
Analyzing the obtained results, it should be noted that 
voltaren has an inhibitory influence in experimental oxi-
dative stress only at concentrations range of toxic doses, 
whereas the antioxidant maldian effect is manifested in 
low doses which effectiveness is of middle rate and ten 
times lower than those of voltaren.
Thus, the ability of maldian to reduce the level of the 
LPO in terms of inflammation is essential in the imple-
mentation of the anti-inflammatory action and its ability 
to normalize the destructive processes caused by the acti-
vation of the FRO.
In our study the mechanism of maldian anti-inflam-
matory action of adrenal system, its antiexudative activity 
on the model of carrageenan swelling in adrenalectomised 
animals has been examined.  The results of the experiment 
are shown in table 6.
Table 6
Maldian antiexudative activity in the experiment on 
adrenalectomized and non-operated rats on the models 
of acute carrageenan swelling (n=8)
Antiexudative activity, %





1 hour of the experiment 24,3 ±2,50 26,6 ±2,70
2 hours of the experiment 33,8 ±3,10 36,0 ±3,09
3 hours of the experiment 46,3 ±2,70 49,1 ±2,65
4 hours of the experiment 54,9 ±3,01 57,3 ±3,49
The results obtained confirmed previously expressed 
antiexudative maldian activity [9], which peaks in 3-4 
hours of the inflammatory response and indicates anticy-
clogenesis mechanism of the anti-inflammatory action of 
the new compound.
Analyzing the obtained data we can conclude that the 
dynamics of antiexudative maldian action of adrenalec-
tomised animals does not differ from that which takes 
place while injecting the substances to non-operated rats 
(table 6.) Statistically significant differences between these 
groups were not established.
Thus, in the implementation of the maldian anti-in-
flammatory effect it’s possible to exclude its influence on 
the adrenal cortex and the activation of the adrenal system.
Conclusions
The mechanisms of realization of the new compound – 
di-(2,4-dimethyl) malonic acid anilide and anti-inflamma-
tory activity of the new compound, under the code name 
– “Maldian” were studied.
Anticyclogenesis mechanism of maldian antiexuda-
tive action at a dose of 7.3 mg/kg was verified by a sig-
nificant decrease of prostaglandin E1 in the blood plasma 
of animals on the background of carrageenan swelling. 
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The effectiveness of the new compound exceeds the anti-
inflammatory effect of voltaren at a dose of 8 mg/kg and 
acetylsalicylic acid at a dose of 98 mg/kg.
Maldian has a reliable inhibitory effect on kallikrein, re-
ducing its content in the blood plasma up to 47% in terms 
of carrageenan swelling, meanwhile significantly exceeds 
the effect of acetylsalicylic acid at a dose of 98 mg/kg.
The antioxidant maldian activity as for the effect on 
lipid peroxidation at the level of voltaren at a dose of 8 mg/
kg was found out.
Maldian has no inducing effect on the adrenal cortex, 
thus eliminating the activation of the adrenal system.
Maldian is a promising compound for further study 
and the introduction into medical practice as an effective 
new anti-inflammatory drug.
References
1. Radulovic M., Bauman W.A., Wecht J.M. et al. Biomarkers of inflam-
mation  in persons with chronic tetraplegia / //J Breath Res. –2015. 
– Vol.9(3). –Р. 360-364.
2. Yang R.,  Chiang N.,  Oh S. F. et al.Metabolomics-lipidomics of eico-
sanoids and docosanoids generated by phagocytes / // Curr Protoc 
Immunol. –2011. – Vol. 14. –Р.  14-26.
3. Ramonda R., Oliviero F., Galozzi P. et al. Molecular mechanisms of 
pain in crystal-induced arthritis // Best Pract Res Clin Rheumatol. 
–  2015.  –  Vol.  29(1). –  Р. 98-110.
4. Ishii T. Close teamwork between Nrf2 and peroxiredoxins 1 and 6 for 
the regulation of prostaglandin D2 and E2 production in macrophages 
in acute inflammation  //Free Radic Biol Med. – 2015 – Vol.88. – Р.189-
198.
5. Ma X.,  Aoki T.,  Tsuruyama T. et al. Definition of Prostaglandin E2-
EP2 Signals in the Colon Tumor Microenvironment That Amplify 
Inflammation and Tumor Growth / // Cancer Res. –2015. – Vol.75 
(14). –Р. 2822-2832.
6. Chaparro M., Gisbert J. P. New molecules in the treatment of inflam-
matory bowel disease //Gastroenterol Hepatol. –  2015. – Vol. 26. – 
Р.210-215.
7. Hanke T., Merk D., Steinhilber D. et al., Small molecules with anti-
inflammatory properties in clinical development / // Pharmacol Ther. 
– 2015. –  Vol.  25. – Р. 163-168.
8. Seyed Mirzaei S.M., Zahedi M. J., Shafiei Pour S. Non-Steroidal Anti-
Inflammatory Drug Related Peptic Ulcer Disease in Patients Referred 
to Afzalipour Hospital / /Middle East J Dig Dis. –  2015. –  Vol.7(4). – Р. 
241-244.
9. Vakhnina N. H. Izuchenie farmakolohicheskoi aktivnosti proizvodnyh 
amidov dikarbovanykh kislot [The study of pharmacological activity 
of amides of dicarboxylic acids derivaties] // Disertastia na soiskanie 
nauchnoi stepeni k. farm. nauk. [The dissertation on PhD in Phar-
macy].- Kharkov.- 1995.-160p. 
10. Reznikov O. H. Zahalni etychni prynstypy eksperementiv na tvarynakh 
[General ethic principals of experiments on animals] // Endocrinolohia 
[Endocrinology] .- 2003.- V. 8, № 1. – Р. 142-145.
11. Doclinichni doslidzhennia likarskykh zasobiv: metod. rec./ za red. O. 
V. Stefanova [Preclinical testing of drug products: method. rek./ by 
O.V. Stefanov].- K.: Avistena, 2001.- 528p. 
12. Pomoinetskii V.D., Nekrasova A.A., Kosykh V.N., Hazarian A.A.  Novye 
aspecty v razvitii I standartizatsii metoda opredelenia proktahladinov v 
biolohicheskikh zhydkostiakhi i tkaniakh [New aspects in the develop-
ment and standardization of a prostaglandins determining method in 
biological fluids and tissues] / //  Vopr. Med. Khimii [The Chemical 
Medicine]. – 1979.- №5.- 636-641.
13. Paskhina T.S., Krinskaya A.V. Uproschyonny metod opredeleniya kal-
likreinohena i kallikreina v syvorotke (plazme) krovi cheloveka v norme 
i pri nekotoryh patolohicheskih  sostoyaniyah [Simplified method for 
determination of kallikreinogen and kallikrein in serum (plasma) of a 
human bloodin norm and atsomepathological conditions].  Voprosy 
meditsinskoi himii [Questions of medical chemistry]. 1974, V. 20, No 
6, 660-663.
14. Lapach S. N. Chubenko A. V., Babich P. N.  Statisticheskie metody v 
medico-biolohicheskikh issledovaniakh s ispolzovaniem Excel  [Sta-
tistical methods in biomedical studies using Excel].  S.N.Lapach,– К. 
: Morion, 2000. – 319 p 
15. Sacerdoti D., Pesce P., Di Pascoli M .et al. /Arachidonic acid metabolites 
and endothelial dysfunction of portal hypertension / / Prostaglan-
dins Other Lipid Mediat. – 2015. –  Vol.  120. – Р. 80-90.
33
